TAK-816
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TAK-816, covering 2013-03-05 to 2016-04-26. Get the full timeline:
Most recent: Clinical Trial Update: Phase III Study of Intramuscular TAK-816 in Healthy Infants [Phase 3]